1.Effect of Psychiatric Prevention and Therapy Program in the Community
Huan-rong LUO ; Xue-jing ZHANG ; Xiao-xuan DENG ; Shaoling XU ; Suping WU ; Yuansong ZHENG ; Dechun WU ; Qunming HUANG ; Jiantao LIU ; Juan XU ; Dahong QIU ; Yuexia LIU
Chinese Journal of Rehabilitation Theory and Practice 2006;12(3):190-191
ObjectiveTo analyze the outcome of psychiatric prevention and therapy program in the community in Huicheng District,Huizhou city.MethodsThe variables of supervision rate,improvement rate,society participation rate,disturbance creating rate of violence,the mean recurrence frequency in one year and hospitalization rate,etc.were observed in psychiatric patients pre-and post initiation of the program as the model of socialization,complexity,accessibility.Results3 years after carrying out the program in Huicheng District of Huizhou city,the supervision rate,improvement rate,society participation rate of psychiatric patients have significantly increased,and the disturbance creating rate of violence,the mean recurrence frequency in one year and hospitalization rate have substantially decreased.ConclusionThe psychiatric prevention and therapy program in the community in Huicheng District,Huizhou city has been shown to be an effective way for psychiatric intervention.
2.Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation.
Xiao-ying QIN ; Guo-xuan LI ; Ya-zhen QIN ; Yu WANG ; Feng-rong WANG ; Dai-hong LIU ; Lan-ping XU ; Huan CHEN ; Wei HAN ; Jing-zhi WANG ; Xiao-hui ZHANG ; Jin-lan LI ; Ling-di LI ; Kai-yan LIU ; Xiao-jun HUANG
Chinese Medical Journal 2011;124(15):2301-2308
BACKGROUNDAnalysis of changes in recipient and donor hematopoietic cell origin is extremely useful to monitor the effect of hematopoietic stem cell transplantation (HSCT) and sequential adoptive immunotherapy by donor lymphocyte infusions. We developed a sensitive, reliable and rapid real-time PCR method based on sequence polymorphism systems to quantitatively assess the hematopoietic chimerism after HSCT.
METHODSA panel of 29 selected sequence polymorphism (SP) markers was screened by real-time PCR in 101 HSCT patients with leukemia and other hematological diseases. The chimerism kinetics of bone marrow samples of 8 HSCT patients in remission and relapse situations were followed longitudinally.
RESULTSRecipient genotype discrimination was possible in 97.0% (98 of 101) with a mean number of 2.5 (1-7) informative markers per recipient/donor pair. Using serial dilutions of plasmids containing specific SP markers, the linear correlation (r) of 0.99, the slope between -3.2 and -3.7 and the sensitivity of 0.1% were proved reproducible. By this method, it was possible to very accurately detect autologous signals in the range from 0.1% to 30%. The accuracy of the method in the very important range of autologous signals below 5% was extraordinarily high (standard deviation <1.85%), which might significantly improve detection accuracy of changes in autologous signals early in the post-transplantation course of follow-up. The main advantage of the real-time PCR method over short tandem repeat PCR chimerism assays is the absence of PCR competition and plateau biases, with demonstrated greater sensitivity and linearity. Finally, we prospectively analyzed bone marrow samples of 8 patients who received allografts and presented the chimerism kinetics of remission and relapse situations that illustrated the sensitivity level and the promising clinical application of this method.
CONCLUSIONThis SP-based real-time PCR assay provides a rapid, sensitive, and accurate quantitative assessment of mixed chimerism that can be useful in predicting graft rejection and early relapse.
Adolescent ; Adult ; Child ; Female ; Genotype ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; genetics ; Real-Time Polymerase Chain Reaction ; methods ; Reproducibility of Results ; Transplantation Chimera ; genetics ; Young Adult
3.Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
Xiao-Ying QIN ; Guo-Xuan LI ; Ya-Zhen QIN ; Yu WANG ; Feng-Rong WANG ; Dai-Hong LIU ; Lan-Ping XU ; Huan CHEN ; Wei HAN ; Jing-Zhi WANG ; Xiao-Hui ZHANG ; Jin-Lan LI ; Ling-di LI ; Kai-Yan LIU ; Xiao-Jun HUANG
Chinese Medical Journal 2012;125(11):1952-1959
BACKGROUNDChimerism analysis is an important tool for the surveillance of post-transplant engraftment. It offers the possibility of identifying impending graft rejection and recurrence of underlying malignant or non-malignant disease. Here we investigated the quantitative chimerism kinetics of 21 relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation (HSCT).
METHODSA panel of 29 selected sequence polymorphism (SP) markers was screened by real-time polymerase chain reaction (RT-PCR) to obtain the informative marker for every leukemia patient. Quantitative chimerism analysis of bone marrow (BM) samples of 21 relapsed patients and 20 patients in stable remission was performed longitudinally. The chimerisms of BM and peripheral blood (PB) samples of 14 patients at relapse were compared.
RESULTSTwenty-one patients experienced leukemia relapse at a median of 135 days (range, 30 - 720 days) after transplantation. High recipient chimerism in BM was found in all patients at relapse, and increased recipient chimerism in BM samples was observed in 90% (19/21) of patients before relapse. With 0.5% recipient DNA as the cut-off, median time between the detection of increased recipient chimerism and relapse was 45 days (range, 0 - 120 days), with 76% of patients showing increased recipient chimerism at least 1 month prior to relapse. Median percentage of recipient DNA in 20 stable remission patients was 0.28%, 0.04%, 0.05%, 0.05%, 0.08%, and 0.05% at 1, 2, 3, 6, 9, and 12 months, respectively, after transplantation. This was concordant with other specific fusion transcripts and fluorescent in situ hybridization examination. The recipient chimerisms in BM were significantly higher than those in PB at relapse (P = 0.001).
CONCLUSIONSThis SP-based RT-PCR assay is a reliable method for chimerism analysis. Chimerism kinetics in BM can be used as a marker of impending leukemia relapse, especially when no other specific marker is available. Based on our findings, we recommend examining not only PB samples but also BM samples in HSCT patients.
Adolescent ; Adult ; Child ; Female ; Hematopoietic Stem Cell Transplantation ; adverse effects ; Humans ; Leukemia ; genetics ; therapy ; Male ; Middle Aged ; Reverse Transcriptase Polymerase Chain Reaction ; Transplantation Chimera ; genetics ; Transplantation, Homologous ; adverse effects ; Young Adult
4.Interpretation of Theory of Weiluo Tongxin and Its Potential Molecular Mechanism Based on Zhishi Xiebai Guizhitang
Feng-rong ZHANG ; Xiao-xuan FAN ; Zhi-yong LI ; Shi-huan TANG
Chinese Journal of Experimental Traditional Medical Formulae 2020;26(24):30-37
The scientific interpretation of the connotation of traditional Chinese medicine (TCM) theory is an important part of the development of TCM. Combined ancient classic theories with modern science and technology is a new path for the innovative development of TCM theory. Based on this, taking Zhishi Xiebai Guizhitang as an example, the molecular mining technology of integrative pharmacology-based research platform of TCM V2.0 (TCMIP V2.0) was used to analyze the mechanism of Zhishi Xiebai Guizhitang in preventing and treating gastropathic stomachache. A total of 220 chemical components in Zhishi Xiebai Guizhitang were obtained, and 674 targets were involved, of which 12 core targets directly affected angina pectoris and gastroesophageal reflux disease, including insulin (INS), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), RAC-
5.Microfluidic Chip and Flow Cytometry for Examination of the Antiplatelet Effect of Ticagrelor.
Xiao-Jing HUANG ; Tian-Cong ZHANG ; Xue-Mei GAO ; Cui HE ; Xuan-Rong HUAN ; Yuan LI
Acta Academiae Medicinae Sinicae 2023;45(2):257-263
Objective To examine the antiplatelet effect of ticagrelor by microfluidic chip and flow cytometry under shear stress in vitro. Methods Microfluidic chip was used to examine the effect of ticagrelor on platelet aggregation at the shear rates of 300/s and 1500/s.We adopted the surface coverage of platelet aggregation to calculate the half inhibition rate of ticagrelor.The inhibitory effect of ticagrelor on ADP-induced platelet aggregation was verified by optical turbidimetry.Microfluidic chip was used to construct an in vitro vascular stenosis model,with which the platelet reactivity under high shear rate was determined.Furthermore,the effect of ticagrelor on the expression of fibrinogen receptor (PAC-1) and P-selectin (CD62P) on platelet membrane activated by high shear rate was analyzed by flow cytometry. Results At the shear rates of 300/s and 1500/s,ticagrelor inhibited platelet aggregation in a concentration-dependent manner,and the inhibition at 300/s was stronger than that at 1500/s (both P<0.001).Ticagrelor at a concentration ≥4 μmol/L almost completely inhibited platelet aggregation.The inhibition of ADP-induced platelet aggregation by ticagrelor was similar to the results under flow conditions and also in a concentration-dependent manner.Ticagrelor inhibited the expression of PAC-1 and CD62P. Conclusion We employed microfluidic chip to analyze platelet aggregation and flow cytometry to detect platelet activation,which can reveal the responses of different patients to ticagrelor.
Humans
;
Ticagrelor/pharmacology*
;
Platelet Aggregation Inhibitors/pharmacology*
;
Flow Cytometry/methods*
;
Microfluidics
;
Platelet Aggregation
6.Effect of breastfeeding on the development of infection-related diseases during hospitalization in late preterm infants in 25 hospitals in Beijing, China.
Lu-Yan HAN ; Xiao-Jing XU ; Xiao-Mei TONG ; Xin ZHANG ; Jie LIU ; Li YANG ; Hui LIU ; Ju YAN ; Zhi-Fang SONG ; Ya-Bo MEI ; Rong MI ; Xuan-Guang QIN ; Yu-Huan LIU ; Yu-Jie QI ; Wei ZHANG ; Hui-Hui ZENG ; Hong CUI ; Hui LONG ; Guo GUO ; Xu-Lin CHEN ; Zhao-Yi YANG ; Fang SUN ; Xiao-Hui FU ; Chang-Yan WANG ; Zheng-Hong LI
Chinese Journal of Contemporary Pediatrics 2020;22(12):1245-1250
OBJECTIVE:
To investigate the incidence rate of infectious diseases during hospitalization in late preterm infants in Beijing, China, as well as the risk factors for infectious diseases and the effect of breastfeeding on the development of infectious diseases.
METHODS:
Related data were collected from the late preterm infants who were hospitalized in the neonatal wards of 25 hospitals in Beijing, China, from October 23, 2015 to October 30, 2017. According to the feeding pattern, they were divided into a breastfeeding group and a formula feeding group. The two groups were compared in terms of general status and incidence rate of infectious diseases. A multivariate logistic regression analysis was used to investigate the risk factors for infectious diseases.
RESULTS:
A total of 1 576 late preterm infants were enrolled, with 153 infants in the breastfeeding group and 1 423 in the formula feeding group. Of all infants, 484 (30.71%) experienced infectious diseases. The breastfeeding group had a significantly lower incidence rate of infectious diseases than the formula feeding group (22.88% vs 31.55%,
CONCLUSIONS
Breastfeeding can significantly reduce the incidence of infectious diseases and is a protective factor against infectious diseases in late preterm infants. Breastfeeding should therefore be actively promoted for late preterm infants during hospitalization.
Beijing/epidemiology*
;
Breast Feeding
;
China/epidemiology*
;
Communicable Diseases/epidemiology*
;
Female
;
Hospitalization
;
Hospitals
;
Humans
;
Incidence
;
Infant
;
Infant, Newborn
;
Infant, Premature
;
Male
;
Pregnancy
7.Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study.
Lu ZHANG ; Yi-Xuan LIU ; Zhe WANG ; Xiao-Qi WANG ; Jing-Jing ZHANG ; Rong-Huan JIANG ; Xiang-Qun WANG ; Shi-Wei ZHU ; Kun WANG ; Zuo-Jing LIU ; Huai-Qiu ZHU ; Li-Ping DUAN
Chinese Medical Journal 2019;132(3):346-351
Adolescent
;
Adult
;
Aged
;
Antidepressive Agents
;
therapeutic use
;
Body Mass Index
;
Depression
;
microbiology
;
Diarrhea
;
microbiology
;
Duloxetine Hydrochloride
;
therapeutic use
;
Feces
;
microbiology
;
Humans
;
Irritable Bowel Syndrome
;
drug therapy
;
microbiology
;
Middle Aged
;
Pilot Projects
;
Probiotics
;
therapeutic use
;
RNA, Ribosomal, 16S
;
genetics
;
Young Adult